Cephalon Tries To Nix Approval For Generic Fentora

Law360, New York (March 16, 2011, 1:23 PM EDT) -- Cephalon Inc. filed suit Tuesday in Washington in an effort to revoke federal approval of Watson Pharmaceuticals Inc.'s generic version of painkiller Fentora, after a judge invalidated two patents covering the drug.

Cephalon filed a complaint in the U.S. District Court for the District of Columbia claiming Watson's planned version of Fentora could be dangerous because its active ingredient is in a different form than in the brand-name drug.

The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services, named as...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.